{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:20:23Z","timestamp":1789078823213,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100006418","name":"Brown University","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100006418","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12954-018-0213-2","type":"journal-article","created":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T07:38:15Z","timestamp":1518075495000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":120,"title":["High willingness to use rapid fentanyl test strips among young adults who use drugs"],"prefix":"10.1186","volume":"15","author":[{"given":"Maxwell S.","family":"Krieger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse L.","family":"Yedinak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane A.","family":"Buxton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lysyshyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josiah D.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Traci C.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Hadland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon D. L.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,8]]},"reference":[{"key":"213_CR1","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","volume":"65","author":"RA Rudd","year":"2016","unstructured":"Rudd RA, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths\u2014United States, 2010\u20132015. MMWR Morb Mortal Wkly Rep. 2016;65:1445\u201352.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"213_CR2","unstructured":"Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System. Provisional counts of drug overdose deaths, as of 8\/6\/2017 [Internet]. 2017. Available from: \n                    https:\/\/www.cdc.gov\/nchs\/data\/health_policy\/monthly-drug-overdose-death-estimates.pdf\n                    \n                  . Accessed 6 Feb 2018."},{"key":"213_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.drugalcdep.2015.12.026","volume":"160","author":"RG Carlson","year":"2016","unstructured":"Carlson RG, Nahhas RW, Martins SS, Daniulaityte R. Predictors of transition to heroin use among initially non-opioid dependent illicit pharmaceutical opioid users: a natural history study. Drug Alcohol Depend. 2016;160:127\u201334.","journal-title":"Drug Alcohol Depend"},{"key":"213_CR4","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1001\/jamapsychiatry.2017.0113","volume":"74","author":"SS Martins","year":"2017","unstructured":"Martins SS, Sarvet A, Santaella-Tenorio J, Saha T, Grant BF, Hasin DS. Changes in US lifetime heroin use and heroin use disorder: prevalence from the 2001\u20132002 to 2012\u20132013 National Epidemiologic Survey on alcohol and related conditions. JAMA Psychiatry. 2017;74:445\u201355.","journal-title":"JAMA Psychiatry"},{"key":"213_CR5","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJMra1508490","volume":"374","author":"WM Compton","year":"2016","unstructured":"Compton WM, Jones CM, Baldwin GT. Relationship between nonmedical prescription-opioid use and heroin use. N Engl J Med. 2016;374:154\u201363.","journal-title":"N Engl J Med"},{"key":"213_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1056\/NEJMc1204141","volume":"367","author":"TJ Cicero","year":"2012","unstructured":"Cicero TJ, Ellis MS, Surratt HL. Effect of abuse-deterrent formulation of OxyContin. N Engl J Med. 2012;367:187\u20139.","journal-title":"N Engl J Med"},{"key":"213_CR7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJMsa1406143","volume":"372","author":"RC Dart","year":"2015","unstructured":"Dart RC, Surratt HL, Cicero TJ, Parrino MW, Severtson SG, Bucher-Bartelson B, et al. Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med. 2015;372:241\u20138.","journal-title":"N Engl J Med"},{"key":"213_CR8","doi-asserted-by":"publisher","first-page":"897","DOI":"10.15585\/mmwr.mm6634a2","volume":"66","author":"JK O\u2019Donnell","year":"2017","unstructured":"O\u2019Donnell JK, Gladden RM, Seth P. Trends in deaths involving heroin and synthetic opioids excluding methadone, and law enforcement drug product reports, by census region\u2014United States, 2006\u20132015. MMWR Morb Mortal Wkly Rep. 2017;66:897\u2013903.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"213_CR9","doi-asserted-by":"publisher","unstructured":"Somerville NJ. Characteristics of fentanyl overdose\u2014Massachusetts, 2014\u20132016. MMWR Morb Mortal Wkly Rep [Internet]. 2017;66 Available from: \n                    https:\/\/doi.org\/10.15585\/mmwr.mm6614a2\n                    \n                  . Accessed 6 Feb 2018.","DOI":"10.15585\/mmwr.mm6614a2"},{"key":"213_CR10","unstructured":"Drug Enforcement Administration. National drug threat assessment summary. Washington, DC: US Department of Justice, Drug Enforcement Administration; 2016. Nov. Available from: \n                    https:\/\/www.hsdl.org\/?abstract&did=797265\n                    \n                  . Accessed 6 Feb 2018."},{"key":"213_CR11","unstructured":"Counterfeit Prescription Pills Containing Fentanyls. A global threat. DEA intelligence brief. Washington, DC: US Department of Justice, Drug Enforcement Administration; 2016. Available from: \n                    https:\/\/www.hsdl.org\/?abstract&did=796541\n                    \n                  . Accessed 6 Feb 2018."},{"key":"213_CR12","unstructured":"Influx of Fentanyl-Laced Counterfeit Pills and Toxic Fentanyl-Related Compounds Further Increases Risk of Fentanyl-Related Overdose and Fatalities. HAN health advisory; 2016. Centers for Disease Control and Prevention; 2016. Available from: \n                    https:\/\/emergency.cdc.gov\/han\/han00395.asp\n                    \n                  . Accessed 6 Feb 2018."},{"key":"213_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6619a1","volume":"66","author":"KA Mack","year":"2017","unstructured":"Mack KA, Jones CM, Ballesteros MF. Illicit drug use, illicit drug use disorders, and drug overdose deaths in metropolitan and nonmetropolitan areas\u2014United States. MMWR Surveill Summ. 2017;66:1\u201312.","journal-title":"MMWR Surveill Summ"},{"key":"213_CR14","doi-asserted-by":"publisher","unstructured":"Dowell D, Noonan RK, Houry D. Underlying factors in drug overdose deaths. JAMA [Internet]. 2017; Available from: \n                    https:\/\/doi.org\/10.1001\/jama.2017.15971\n                    \n                  . Accessed 6 Feb 2018.","DOI":"10.1001\/jama.2017.15971"},{"key":"213_CR15","doi-asserted-by":"publisher","first-page":"837","DOI":"10.15585\/mmwr.mm6533a2","volume":"65","author":"RM Gladden","year":"2016","unstructured":"Gladden RM, Martinez P, Fentanyl Law SP. Enforcement submissions and increases in synthetic opioid-involved overdose deaths\u201427 states, 2013\u20132014. MMWR Morb Mortal Wkly Rep. 2016;65:837\u201343.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"213_CR16","unstructured":"Office of the Chief Coroners. Fentanyl-Detected Illicit Drug Overdose Deaths (January 1, 2012 to August 31, 2017) [Internet]. British Columbia Coroners Service; 2017 Oct. Available from: \n                    https:\/\/www2.gov.bc.ca\/assets\/gov\/public-safety-and-emergency-services\/death-investigation\/statistical\/fentanyl-detected-overdose.pdf\n                    \n                  . Accessed 6 Feb 2018."},{"key":"213_CR17","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1111\/ajt.13776","volume":"16","author":"RA Rudd","year":"2016","unstructured":"Rudd RA, Aleshire N, Zibbell JE, Matthew Gladden R. Increases in drug and opioid overdose deaths\u2014United States, 2000\u20132014. Am J Transplant. 2016;16:1323\u20137.","journal-title":"Am J Transplant"},{"key":"213_CR18","doi-asserted-by":"publisher","first-page":"719","DOI":"10.15585\/mmwr.mm6430a5","volume":"64","author":"CM Jones","year":"2015","unstructured":"Jones CM, Logan J, Gladden RM, Bohm MK. Vital signs: demographic and substance use trends among heroin users\u2014United States, 2002\u20132013. MMWR Morb Mortal Wkly Rep. 2015;64:719\u201325.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"213_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.drugpo.2017.05.029","volume":"46","author":"BDL Marshall","year":"2017","unstructured":"Marshall BDL, Krieger MS, Yedinak JL, Ogera P, Banerjee P, Alexander-Scott NE, et al. Epidemiology of fentanyl-involved drug overdose deaths: a geospatial retrospective study in Rhode Island, USA. Int. J. Drug Policy. 2017;46:130\u20135.","journal-title":"Int. J. Drug Policy."},{"key":"213_CR20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.drugpo.2014.07.013","volume":"26","author":"D Frank","year":"2015","unstructured":"Frank D, Mateu-Gelabert P, Guarino H, Bennett A, Wendel T, Jessell L, et al. High risk and little knowledge: overdose experiences and knowledge among young adult nonmedical prescription opioid users. Int. J. Drug Policy. 2015;26:84\u201391.","journal-title":"Int. J. Drug Policy."},{"key":"213_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.drugpo.2016.01.022","volume":"31","author":"BDL Marshall","year":"2016","unstructured":"Marshall BDL, Green TC, Yedinak JL, Hadland SE. Harm reduction for young people who use prescription opioids extra-medically: obstacles and opportunities. Int J Drug Policy. 2016;31:25\u201331.","journal-title":"Int J Drug Policy"},{"key":"213_CR22","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.drugpo.2017.06.004","volume":"46","author":"D Ciccarone","year":"2017","unstructured":"Ciccarone D, Ondocsin J, Mars SG. Heroin uncertainties: exploring users\u2019 perceptions of fentanyl-adulterated and -substituted \u201cheroin\u201d. International Journal of Drug Policy. 2017;46:146\u201355.","journal-title":"International Journal of Drug Policy"},{"key":"213_CR23","unstructured":"Akins T. Drug checking at Insite shows potential for preventing fentanyl-related overdoses [Internet]. Vancouver Coastal Health. 2017 [cited 2017 Nov 9]. Available from: \n                    http:\/\/www.vch.ca\/about-us\/news\/news-releases\/drug-checking-at-insite-shows-potential-for-preventing-fentanyl-related-overdoses\n                    \n                  . Accessed 6 Feb 2018."},{"key":"213_CR24","unstructured":"Mark Lysyshyn, Carolyn Dohoo, Sara Forsting, Thomas Kerr, Ryan McNeil. Evaluation of a fentanyl drug checking program for clients of a supervised injection site, Vancouver, Canada. [cited 2017 Nov 9]. Available from: \n                    https:\/\/www.hri.global\/files\/2017\/05\/14\/188_Lysyshyn.docx\n                    \n                  . Accessed 06 Feb 2018."},{"key":"213_CR25","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1207\/s15324796abm3101_11","volume":"31","author":"ES Anderson","year":"2006","unstructured":"Anderson ES, Wagstaff DA, Heckman TG, Winett RA, Roffman RA, Solomon LJ, et al. Information-motivation-behavioral skills (IMB) model: testing direct and mediated treatment effects on condom use among women in low-income housing. Ann Behav Med. 2006;31:70\u20139.","journal-title":"Ann Behav Med"},{"key":"213_CR26","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1007\/s10461-016-1309-x","volume":"20","author":"W Brown 3rd","year":"2016","unstructured":"Brown W 3rd, Carballo-Di\u00e9guez A, John RM, Schnall R. Information, motivation, and behavioral skills of high-risk young adults to use the HIV self-test. AIDS Behav. 2016;20:2000\u20139.","journal-title":"AIDS Behav"},{"key":"213_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.addbeh.2017.01.014","volume":"68","author":"A Macmadu","year":"2017","unstructured":"Macmadu A, Carroll JJ, Hadland SE, Green TC, BDL M. Prevalence and correlates of fentanyl-contaminated heroin exposure among young adults who use prescription opioids non-medically. Addict Behav. 2017;68:35\u20138.","journal-title":"Addict Behav"},{"key":"213_CR28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12954-015-0088-4","volume":"12","author":"A Amlani","year":"2015","unstructured":"Amlani A, McKee G, Khamis N, Raghukumar G, Tsang E, Buxton JA. Why the FUSS (Fentanyl urine screen study)? A cross-sectional survey to characterize an emerging threat to people who use drugs in British Columbia, Canada. Harm Reduct J. 2015;12:54. BioMed Central","journal-title":"Harm Reduct J"},{"key":"213_CR29","unstructured":"BTNX | Fentanyl (FYL) Test Strip [Internet]. [cited 2017 Oct 18]. Available from: \n                    http:\/\/www.btnx.com\/Product?id=2002\n                    \n                  . Accessed 6 Feb 2018."},{"key":"213_CR30","doi-asserted-by":"publisher","unstructured":"Armenian P, Vo KT, Barr-Walker J, Lynch KL. Fentanyl, fentanyl analogs and novel synthetic opioids: a comprehensive review. Neuropharmacology [Internet]. 2017; Available from: \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2017.10.016\n                    \n                  . Accessed 6 Feb 2018.","DOI":"10.1016\/j.neuropharm.2017.10.016"},{"key":"213_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.drugalcdep.2016.02.024","volume":"162","author":"A Caudarella","year":"2016","unstructured":"Caudarella A, Dong H, Milloy MJ, Kerr T, Wood E, Hayashi K. Non-fatal overdose as a risk factor for subsequent fatal overdose among people who inject drugs. Drug Alcohol Depend. 2016;162:51\u20135.","journal-title":"Drug Alcohol Depend"},{"key":"213_CR32","doi-asserted-by":"crossref","unstructured":"Coffin PO, Tracy M, Bucciarelli A, Ompad D, Vlahov D, Galea S. Identifying injection drug users at risk of nonfatal overdose. Acad Emerg Med. 2007;14:616\u201323.","DOI":"10.1197\/j.aem.2007.04.005"},{"key":"213_CR33","unstructured":"Stewart B. Demand for fentanyl test strips booms\u2014but test is not widely available [Internet]. CBC News. 2017 [cited 2017 Nov 29]. Available from: \n                    http:\/\/a.msn.com\/01\/en-ca\/BBFRkAq?ocid=se\n                    \n                  . Accessed 6 Feb 2018."},{"key":"213_CR34","unstructured":"Bebinger M. As Fentanyl Deaths Rise, An Off-Label Tool Becomes A Test For The Killer Opioid [Internet]. WBUR. 2017 [cited 2017 Oct 17]. Available from: \n                    http:\/\/www.wbur.org\/commonhealth\/2017\/05\/11\/fentanyl-test-strips\n                    \n                  . Accessed 6 Feb 2018."},{"key":"213_CR35","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/dta.1954","volume":"9","author":"TM Brunt","year":"2017","unstructured":"Brunt TM, Nagy C, B\u00fccheli A, Martins D, Ugarte M, Beduwe C, et al. Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project. Drug Test Anal. 2017;9:188\u201398.","journal-title":"Drug Test Anal"},{"key":"213_CR36","unstructured":"McKee G, Amlani A, Buxton - BCMJ J, 2015. Illicit fentanyl: An emerging threat to people who use drugs in BC. \n                    researchgate.net\n                    \n                   [Internet]. 2015; Available from: \n                    http:\/\/www.bcmj.org\/bc-centre-disease-control\/illicit-fentanyl-emerging-threat-people-who-use-drugs-bc\n                    \n                  . Accessed 6 Feb 2018."},{"key":"213_CR37","first-page":"235","volume":"88","author":"KF Hawk","year":"2015","unstructured":"Hawk KF, Vaca FE, D\u2019Onofrio G. Reducing fatal opioid overdose: prevention, treatment and harm reduction strategies. Yale J Biol Med. 2015;88:235\u201345.","journal-title":"Yale J Biol Med"},{"key":"213_CR38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3109\/00952990.2011.600389","volume":"38","author":"K DeBeck","year":"2012","unstructured":"DeBeck K, Kerr T, Lai C, Buxton J, Montaner J, Wood E. The validity of reporting willingness to use a supervised injecting facility on subsequent program use among people who use injection drugs. Am J Drug Alcohol Abuse. 2012;38:55\u201362.","journal-title":"Am J Drug Alcohol Abuse"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-018-0213-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T19:37:32Z","timestamp":1549568252000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-018-0213-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,8]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["213"],"URL":"https:\/\/doi.org\/10.1186\/s12954-018-0213-2","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,8]]},"assertion":[{"value":"7 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Our research was performed in accordance with the Declaration of Helsinki and received approval from the Brown University Office of Research Protections IRB, #1612001662. All participants provided written consent at the time of the survey.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"7"}}